Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47) 47
Book / eBook (18) 18
Publication (9) 9
Newspaper Article (6) 6
Book Review (4) 4
Conference Proceeding (2) 2
Dissertation (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
Patent (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24) 24
humans (22) 22
male (19) 19
female (17) 17
adult (15) 15
infectious diseases (14) 14
middle aged (13) 13
hiv infections - drug therapy (12) 12
human immunodeficiency virus--hiv (9) 9
antiretroviral therapy (8) 8
cd4 lymphocyte count (8) 8
hiv (8) 8
research (8) 8
acquired immune deficiency syndrome--aids (7) 7
antiretroviral drugs (7) 7
risk factors (7) 7
anti-hiv agents - therapeutic use (6) 6
antiviral agents (6) 6
hiv infection (6) 6
hiv infections - epidemiology (6) 6
medical research (6) 6
mortality (6) 6
treatment outcome (6) 6
health aspects (5) 5
hiv infections - complications (5) 5
human-immunodeficiency-virus (5) 5
immunology (5) 5
infected patients (5) 5
life sciences (5) 5
management (5) 5
medicine, general & internal (5) 5
risk (5) 5
viral load (5) 5
abridged index medicus (4) 4
active antiretroviral therapy (4) 4
aids (4) 4
analysis (4) 4
care and treatment (4) 4
cd4 antigen (4) 4
chemistry, multidisciplinary (4) 4
cohort studies (4) 4
complications and side effects (4) 4
education (4) 4
emtricitabine (4) 4
europe (4) 4
genotype (4) 4
germany (4) 4
highly active antiretroviral therapy (4) 4
history (4) 4
hiv-1-infected patients (4) 4
human immunodeficiency virus (4) 4
infection (4) 4
infectious disease (4) 4
internal medicine (4) 4
kaplan-meier estimate (4) 4
ligands (4) 4
medicine (4) 4
medicine, experimental (4) 4
patients (4) 4
physics (4) 4
science (4) 4
therapy (4) 4
acquired immune deficiency syndrome (3) 3
anti-hiv agents - adverse effects (3) 3
antiretroviral therapy, highly active - methods (3) 3
cardiovascular diseases - epidemiology (3) 3
chemistry (3) 3
complex organizations (3) 3
diseases (3) 3
dosage and administration (3) 3
drug therapy (3) 3
europe - epidemiology (3) 3
hiv infections - immunology (3) 3
hiv infections - virology (3) 3
hiv patients (3) 3
hiv-1 (3) 3
infections (3) 3
inflammation (3) 3
multidisciplinary sciences (3) 3
nanocrystals (3) 3
netherlands - epidemiology (3) 3
organisatiesociologie; algemeen (3) 3
organisation (3) 3
organization (3) 3
quantum dots (3) 3
risk-factors (3) 3
semiconductor nanocrystals (3) 3
sociologie des organisations (3) 3
tenofovir (3) 3
time factors (3) 3
united states (3) 3
virology (3) 3
610 medicine & health (2) 2
[chim.inor]chemical sciences/inorganic chemistry (2) 2
[phys.cond.cm-ms]physics [physics]/condensed matter [cond-mat]/materials science [cond-mat.mtrl-sci] (2) 2
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (2) 2
abacavir-lamivudine (2) 2
adolescent (2) 2
aged (2) 2
aids/hiv (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
OISE - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Criminology - Stacks (1) 1
Faculty of Information - Stacks (1) 1
OISE - Missing (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
by Smith, Colette J, Dr and Ryom, Lene, PhD and Weber, Rainer, Prof and Morlat, Philippe, PhD and Pradier, Christian, Prof and Reiss, Peter, Prof and Kowalska, Justyna D, PhD and de Wit, Stephane, PhD and Law, Matthew, Prof and el Sadr, Wafaa, Prof and Kirk, Ole, DMSc and Friis-Moller, Nina, DMSc and Monforte, Antonella d'Arminio, MD and Phillips, Andrew N, Prof and Sabin, Caroline A, Prof and Lundgren, Jens D, Prof and D A D Study Grp and D:A:D Study Group
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9939, pp. 241 - 248
Summary Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MYOCARDIAL-INFARCTION | DATA-COLLECTION | ANTIRETROVIRAL THERAPY | INFECTION | AIDS-DEFINING CANCERS | HUMAN-IMMUNODEFICIENCY-VIRUS | HEPATITIS-C | ADVERSE EVENTS | United States - epidemiology | Humans | Middle Aged | Risk Factors | Europe - epidemiology | Male | Australia - epidemiology | Acquired Immunodeficiency Syndrome - mortality | Adult | Cause of Death - trends | Female | HIV Infections - mortality | Poisson Distribution | Antiviral agents | Care and treatment | Patient outcomes | Death | Research | HIV infection | Risk factors | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Factors affecting transmission of mucosal human papillomavirus
by Veldhuijzen, Nienke J, Dr and Snijders, Peter JF, Prof and Reiss, Peter, Prof and Meijer, Chris JLM, Prof and van de Wijgert, Janneke HHM, PhD
Lancet Infectious Diseases, The, ISSN 1473-3099, 2010, Volume 10, Issue 12, pp. 862 - 874
Summary Human papillomavirus (HPV) is the most common sexually transmitted infection. The effect of HPV on public health is especially related to the burden of... 
Infectious Disease | FEMALE UNIVERSITY-STUDENTS | INFECTIOUS DISEASES | CHLAMYDIA-TRACHOMATIS INFECTION | SEXUALLY-TRANSMITTED INFECTIONS | HIV-NEGATIVE WOMEN | ACTIVE ANTIRETROVIRAL THERAPY | SUBSEQUENT HPV INFECTION | POPULATION-BASED COHORT | HUMAN-IMMUNODEFICIENCY-VIRUS | CERVICAL INTRAEPITHELIAL NEOPLASIA | RISK HUMAN-PAPILLOMAVIRUS | Prevalence | Mucous Membrane - virology | Humans | Papillomavirus Infections - epidemiology | Risk Factors | Male | Disease Transmission, Infectious - prevention & control | Papillomaviridae - pathogenicity | Sexually Transmitted Diseases, Viral - transmission | Sexually Transmitted Diseases, Viral - epidemiology | Sexually Transmitted Diseases, Viral - virology | Female | Papillomavirus Infections - virology | Papillomavirus Infections - transmission | Papillomaviruses | Highly active antiretroviral therapy | Sexually transmitted diseases | Disease susceptibility | Health aspects | Papillomavirus infections | Public health | Cervical cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
by Mocroft, Amanda, Prof and Lundgren, Jens D, Prof and Ross, Michael, MD and Fux, Christoph A and Reiss, Peter, Prof and Moranne, Olivier, MD and Morlat, Philippe, MD and Monforte, Antonella d'Arminio, Prof and Kirk, Ole, DMSc and Ryom, Lene, MD and Data Collection Adverse Events and Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study
Lancet HIV, The, ISSN 2352-3018, 2016, Volume 3, Issue 1, pp. e23 - e32
Summary Background Whether or not the association between some antiretrovirals used in HIV infection and chronic kidney disease is cumulative is a... 
Infectious Disease | PROTEASE INHIBITOR | INFECTIOUS DISEASES | TENOFOVIR DISOPROXIL FUMARATE | INFECTED INDIVIDUALS | RISK-FACTORS | THERAPY | NAIVE PATIENTS | EFAVIRENZ | RENAL-FUNCTION | CREATININE | IMMUNOLOGY | ASSOCIATION | Prospective Studies | Tenofovir - adverse effects | Renal Insufficiency, Chronic - etiology | Tenofovir - therapeutic use | United States | Anti-HIV Agents - adverse effects | Europe | Humans | Middle Aged | Male | Atazanavir Sulfate - adverse effects | Renal Insufficiency, Chronic - physiopathology | Atazanavir Sulfate - therapeutic use | Young Adult | Glomerular Filtration Rate - drug effects | Adolescent | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Australia | Life Sciences | Human health and pathology | Immunology | Infectious diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Bone mineral density and inflammatory and bone biomarkers after darunavir–ritonavir combined with either raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
by Bernardino, Jose I, Dr and Mocroft, Amanda, PhD and Mallon, Patrick W, PhD and Wallet, Cedrick, MSc and Gerstoft, Jan, Prof and Russell, Charlotte, BSc and Reiss, Peter, Prof and Katlama, Christine, MD and De Wit, Stephane, MD and Richert, Laura, PhD and Babiker, Abdel, Prof and Buño, Antonio, MD and Castagna, Antonella, MD and Girard, Pierre-Marie, MD and Chene, Genevieve, Prof and Raffi, Francois, Prof and Arribas, Jose R, MD and NEAT001 ANRS143 Study Grp and NEAT001/ANRS143 Study Group
Lancet HIV, The, ISSN 2352-3018, 2015, Volume 2, Issue 11, pp. e464 - e473
Summary Background Osteopenia, osteoporosis, and low bone mineral density are frequent in patients with HIV. We assessed the 96 week loss of bone mineral... 
Infectious Disease | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | THERAPY INITIATION | TURNOVER | DISOPROXIL FUMARATE | MARKERS | HIV-1-INFECTED PATIENTS | INFECTED PATIENTS | PREVALENCE | IMMUNOLOGY | FRACTURE RISK | OSTEOPOROSIS | Raltegravir Potassium - adverse effects | Bone Diseases, Metabolic - epidemiology | Osteopetrosis - physiopathology | HIV Infections - epidemiology | Humans | Middle Aged | Raltegravir Potassium - administration & dosage | Male | Tenofovir - administration & dosage | Osteopetrosis - chemically induced | Viral Load | Anti-HIV Agents - administration & dosage | Ritonavir - adverse effects | Darunavir - administration & dosage | Adult | Female | Drug Therapy, Combination | Emtricitabine - administration & dosage | Emtricitabine - adverse effects | Tenofovir - adverse effects | Ritonavir - administration & dosage | Comorbidity | Anti-HIV Agents - adverse effects | Europe - epidemiology | CD4 Lymphocyte Count | Biomarkers - blood | Bone Diseases, Metabolic - chemically induced | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Osteopetrosis - epidemiology | HIV Infections - drug therapy | Darunavir - adverse effects | Bone Diseases, Metabolic - physiopathology | Inflammation - physiopathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Obituary: Prof. (TV) h.c. Dr. med. dent. Peter Schletter
by Schenk, Olaf and Wiedhahn, Klaus and Reiss, Bernd
International journal of computerized dentistry, ISSN 1463-4201, 2015, Volume 18, Issue 4, pp. 381 - 383
Dentists - history | History, 21st Century | History, 20th Century | Humans | Germany
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prof. (TV) h.c. Dr. med. dent. Peter Schletter OBITUARY
by Schenk, O and Wiedhahn, K and Reiss, B
INTERNATIONAL JOURNAL OF COMPUTERIZED DENTISTRY, ISSN 1463-4201, 2015, Volume 18, Issue 4, pp. 381 - 383
DENTISTRY, ORAL SURGERY & MEDICINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Research in action: From AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange
by Boender, T. Sonia and Barré-Sinoussi, Françoise and Cooper, David and Goosby, Eric and Hankins, Catherine and Heidenrijk, Michiel and De Jong, Menno and Kazatchkine, Michel and Laoye, Fola and Merson, Michael and Reiss, Peter and Rinke De Wit, Tobias F and Rogo, Khama and Schellekens, Onno and Schultsz, Constance and Sigaloff, Kim C. E and Simon, John and Zewdie, Debrework
Antiviral Therapy, ISSN 1359-6535, 2015, Volume 20, Issue 1, pp. 101 - 108
On Tuesday 14 October 2014, 850 family members, friends, colleagues, prominent scientists and dignitaries from all over the world gathered in Amsterdam to pay... 
INFECTIOUS DISEASES | VIROLOGY | ZIDOVUDINE | RETROVIRUS | RISK | PHARMACOLOGY & PHARMACY | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | NEVIRAPINE
Journal Article
Details down arrow
8. Full Text Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
by Raffi, François, Prof and Babiker, Abdel G, Prof and Richert, Laura, PhD and Molina, Jean-Michel, Prof and George, Elizabeth C, MSc and Antinori, Andrea, MD and Arribas, Jose R, MD and Grarup, Jesper, DVM and Hudson, Fleur, BA and Schwimmer, Christine, PhD and Saillard, Juliette, MSc and Wallet, Cédrick, MSc and Jansson, Per O, RN and Allavena, Clotilde, MD and Van Leeuwen, Remko, PhD and Delfraissy, Jean-François, Prof and Vella, Stefano, MD and Chêne, Geneviève, Prof and Pozniak, Anton, MD and NEAT001 ANRS143 Study Grp
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9958, pp. 1942 - 1951
Summary Background Standard first-line antiretroviral therapy for HIV-1 infection includes two nucleoside or nucleotide reverse transcriptase inhibitors... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | DOUBLE-BLIND | SPARING REGIMENS | INITIAL TREATMENT | HIV-1-INFECTED PATIENTS | LOPINAVIR/RITONAVIR | TENOFOVIR/EMTRICITABINE | ONCE-DAILY DARUNAVIR/RITONAVIR | PLUS RALTEGRAVIR | Complications and side effects | Reverse transcriptase inhibitors | Dosage and administration | Drug therapy | HIV infection | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights